Literature DB >> 17897039

Mini review on molecular modeling of P-glycoprotein (Pgp).

Sookhee N Ha1, Jerome Hochman, Robert P Sheridan.   

Abstract

Membrane bound P-glycoprotein (Pgp) acts as an active transport pump. It plays a major role as a cause of multidrug resistance (MDR) and acts as a component of the blood-brain barrier. Pgp transports a wide variety of structurally unrelated compound from the cell interior into the extracellular space. Recent molecular modeling efforts, mostly in homology modeling and QSAR studies, have brought some understanding to the interactions between the protein and the drugs at the atomic level. We review the recent developments from the point of view of methodology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17897039     DOI: 10.2174/156802607782194806

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  10 in total

Review 1.  Membrane transporters in drug development.

Authors:  Kathleen M Giacomini; Shiew-Mei Huang; Donald J Tweedie; Leslie Z Benet; Kim L R Brouwer; Xiaoyan Chu; Amber Dahlin; Raymond Evers; Volker Fischer; Kathleen M Hillgren; Keith A Hoffmaster; Toshihisa Ishikawa; Dietrich Keppler; Richard B Kim; Caroline A Lee; Mikko Niemi; Joseph W Polli; Yuichi Sugiyama; Peter W Swaan; Joseph A Ware; Stephen H Wright; Sook Wah Yee; Maciej J Zamek-Gliszczynski; Lei Zhang
Journal:  Nat Rev Drug Discov       Date:  2010-03       Impact factor: 84.694

Review 2.  The blood-brain barrier.

Authors:  Richard Daneman; Alexandre Prat
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-01-05       Impact factor: 10.005

3.  HG-829 is a potent noncompetitive inhibitor of the ATP-binding cassette multidrug resistance transporter ABCB1.

Authors:  Gisela Caceres; Robert W Robey; Lubomir Sokol; Kathy L McGraw; Justine Clark; Nicholas J Lawrence; Said M Sebti; Michael Wiese; Alan F List
Journal:  Cancer Res       Date:  2012-07-03       Impact factor: 12.701

4.  Prediction of biliary excretion in rats and humans using molecular weight and quantitative structure-pharmacokinetic relationships.

Authors:  Xinning Yang; Yash A Gandhi; David B Duignan; Marilyn E Morris
Journal:  AAPS J       Date:  2009-07-11       Impact factor: 4.009

Review 5.  Structure-activity relationships and quantitative structure-activity relationships for breast cancer resistance protein (ABCG2).

Authors:  Yash A Gandhi; Marilyn E Morris
Journal:  AAPS J       Date:  2009-07-24       Impact factor: 4.009

6.  Influence of multidrug resistance on (18)F-FCH cellular uptake in a glioblastoma model.

Authors:  Claire Vanpouille; Nathalie Le Jeune; David Kryza; Anthony Clotagatide; Marc Janier; Francis Dubois; Nathalie Perek
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03-20       Impact factor: 9.236

7.  Novel Treatment Approaches for Brain Tumour from a Blood-Brain Barrier Perspective.

Authors:  Sheng-Kai Wu; Chia-Lin Tsai; Kullervo Hynynen
Journal:  Handb Exp Pharmacol       Date:  2022

Review 8.  Lipid-Based Nanocarriers for Neurological Disorders: A Review of the State-of-the-Art and Therapeutic Success to Date.

Authors:  Bwalya Angel Witika; Madan Sai Poka; Patrick Hulisani Demana; Scott Kaba Matafwali; Siyabonga Melamane; Sandile Maswazi Malungelo Khamanga; Pedzisai Anotida Makoni
Journal:  Pharmaceutics       Date:  2022-04-11       Impact factor: 6.525

9.  Applicability of free drug hypothesis to drugs with good membrane permeability that are not efflux transporter substrates: A microdialysis study in rats.

Authors:  Chun Chen; Hongyu Zhou; Chi Guan; Huanhuan Zhang; Yingying Li; Xue Jiang; Zheng Dong; Yuanyuan Tao; Juan Du; Shuyao Wang; Teng Zhang; Na Du; Junyang Guo; Yaqiong Wu; Zehai Song; Haofei Luan; Yu Wang; Hongwen Du; Shaofeng Zhang; Chen Li; Hang Chang; Tao Wang
Journal:  Pharmacol Res Perspect       Date:  2020-04

Review 10.  Structure and Junctional Complexes of Endothelial, Epithelial and Glial Brain Barriers.

Authors:  Mariana Castro Dias; Josephine A Mapunda; Mykhailo Vladymyrov; Britta Engelhardt
Journal:  Int J Mol Sci       Date:  2019-10-29       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.